Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Finished Goods (2023 - 2025)

Onconetix (ONCO) has disclosed Finished Goods for 2 consecutive years, with $23919.0 as the latest value for Q3 2024.

  • On a quarterly basis, Finished Goods changed N/A to $23919.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $23919.0, a N/A change, with the full-year FY2023 number at $30039.0, changed N/A from a year prior.
  • Finished Goods was $23919.0 for Q3 2024 at Onconetix, down from $68301.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $68301.0 in Q2 2024 to a low of $4966.0 in Q1 2024.